ZURICH (Reuters) – Swiss drugmaker Roche said on Wednesday a late-stage study of its treatment for slow-growing, or indolent, non-Hodgkin’s lymphoma showed significant benefit and met its primary endpoint early. The study showed that people lived …
Source: Roche says study of lymphoma drug shows significant benefit
Wednesday, February 4, 2015
Roche says study of lymphoma drug shows significant benefit
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment